The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
Defending champions Arsenal squeezed into the FA Cup final despite a spirited fightback from Reading, who forced extra-time
A detective who led investigations into the Valley Parade fire tells ITV News there is "unequivocal" evidence the disaster was an accident.
Tonight will start off clear in many areas, but cloud will increase from the east overnight, bringing some light and patchy rain.